Prospective Effect of Intravenous Ketorolac on Opioid Use and Complications Following Cesarean Delivery
Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double blind placebo trial to evaluate whether ketorolac given at the
time of cord clamp has any impact on post-partum pain control. Patients will be randomized to
either placebo or ketorolac prior to surgery. Those randomized to ketorolac will receive
ketorolac at cord clamp and 3 additional doses 6 hours apart (total 4 doses/24 hours). Those
in the placebo group will receive placebo medications during those time periods.